Psoriasis: all 1,928 studies
Page 18 of 20. Open to participants first (234), then studies with results posted, then the rest; newest registration first within each.
- The Influence of Adalimumab on Cardiovascular and Metabolic Risk in PsoriasisStatus unknownNCT01088165Phase 4
- Ustekinumab Safety and Surveillance Program Using the Ingenix NHI DatabaseCompletedNCT01081730
- Analysis of the Quality of Life, the Clinical Effectiveness and Cost-effectiveness of a Novel Educational Programme in Patients With Psoriasis and Atopic DermatitisCompletedNCT01077882Phase 4
- Documentation of Humira in Psoriasis Patients in Routine Clinical PracticeCompletedNCT01077232
- Safety and Efficacy of Multiple Doses of BT061 in Patients With Moderate to Severe Chronic Plaque PsoriasisCompletedNCT01072383Phase 2
- Topical Treatment of Scalp Psoriasis With the Fixed Combination of Calcipotriol and Betamethason (Xamiol® Gel)CompletedNCT01052467
- STA-21 Topical Efficacy on PsoriasisCompletedNCT01047943Phase 1/2
- A Double-blind, Placebo-controlled, Randomized, Parallel-group Study to Evaluate the Activity of Oral AB1010 in Adults Patients With Moderate to Severe Chronic Plaque PsoriasisCompletedNCT01045577Phase 2
- Efficacy of Two Algae Formulations on Lipid Metabolism, Inflammation and Oxidative Stress Status in Individuals With PsoriasisCompletedNCT01045395Phase 1
- A Psoriasis Plaque Test Comparing Products for the Treatment of Psoriasis VulgarisCompletedNCT01043224Phase 1
- Dose Ranging Study to Assess the Efficacy and Safety of Acitretin in Severe Plaque Type PsoriasisCompletedNCT01039142Phase 4
- Serum Lipid Levels and Other Biomarkers of Cardiovascular Disease in Patients With PsoriasisCompletedNCT01019200
- Efficacy and Tolerability of Prednisolone Acetate 0.5% Cream Versus Betamethasone Valerate 0.1% Cream in Cortisosensitive DermatosisStatus unknownNCT01011621Phase 3
- Erlotinib for Treatment of PsoriasisWithdrawnNCT01006096Phase 2
- Study to Assess VB-201 in Patients With PsoriasisCompletedNCT01001468Phase 2
- Determination of the Efficacy and Safety of Psirelax in the Relief of the Disease in PsoriasisCompletedNCT01000714Phase 2
- Study Evaluating The Prevalence Of Undiagnosed Psoriatic Arthritis In Patients With Plaque PsoriasisCompletedNCT00998829
- CT 327 in the Treatment of Psoriasis VulgarisCompletedNCT00995969Phase 2
- Safety and Efficacy of BFH772 in Psoriasis PatientsCompletedNCT00987870Phase 1/2
- Evaluation of Clinical Outcomes in an Online Teledermatology Model for the Management of PsoriasisCompletedNCT00971477Phase 2
- Safety and Efficacy of Etanercept in Patients With Psoriasis Who Failed to Respond to Other Biologic TreatmentsCompletedNCT00967538Phase 4
- An Efficacy and Safety Study of PH-10 Aqueous Hydrogel for the Treatment of Plaque PsoriasisCompletedNCT00941278Phase 2
- Effect of Adalimumab on Vascular Inflammation in Patients With Moderate to Severe Plaque PsoriasisCompletedNCT00940862Phase 4
- Aminopterin Pharmacokinetic Study In Moderate to Severe PsoriasisCompletedNCT00937027Phase 1
- Peds Metabolic Syndrome in PsoriasisCompletedNCT00930592
- A Case Control Study Evaluating the Prevalence of Non-Alcoholic Fatty Liver Disease Among Patients With PsoriasisCompletedNCT00930384
- A Study of the Safety and How the Body Affects a Drug (CNTO 1959) in Healthy Volunteers and in Patients With PsoriasisCompletedNCT00925574Phase 1
- Prevalence of Sleep Disturbances in PsoriasisCompletedNCT00895375
- Study Evaluating Management of Patients With Moderate and Severe PsoriasisCompletedNCT00894777
- Premature Coronary Artery Disease (CAD) in Severe PsoriasisCompletedNCT00893126
- A Dose Finding Study of AEB071 Assessing Psoriasis Area and Severity Index in Patients With Plaque PsoriasisCompletedNCT00885196Phase 2
- Study to Investigate the Efficacy and the Safety of M518101 in Psoriasis PatientsCompletedNCT00884169Phase 2
- Impact of the Severity of Pediatric Psoriasis on Childhood Body Mass IndexCompletedNCT00879944
- BTT1023 in PsoriasisCompletedNCT00871598Phase 1
- Ustekinumab Plus UVB-311nm in PsoriasisCompletedNCT00870285Not applicable
- ACT-128800 in PsoriasisCompletedNCT00852670Phase 2
- Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Doses of AbGn-168 in PsoriasisCompletedNCT00848055Phase 1
- Narrowband UVB Phototherapy in the Treatment of Psoriasis VulgarisTerminatedNCT00844363Not applicable
- Prevalence of Psoriasis Alba in Psoriatic PatientsStatus unknownNCT00835315
- LEO 22811 - A Phase 1, Double-Blind, Placebo-controlled, Single and Multiple Oral Dose Study in Healthy SubjectsCompletedNCT00833872Phase 1
- The Safety & Efficacy of Etanercept in Psoriasis Patients Who Have Not Responded to AdalimumabCompletedNCT00833729Phase 4
- Trial of an Injectable Biologic and U0279 as Combination Therapy for Severe Plaque-Type PsoriasisWithdrawnNCT00832364Phase 4
- Double-Blind Study of Topical WBI-1001 Cream on Patients With PsoriasisCompletedNCT00830817
- Combined Inhibition of Dipeptidyl Peptidase IV (DPIV/CD26) and Aminopeptidase N (APN/CD13) in the Treatment of PsoriasisStatus unknownNCT00824980Phase 2
- Exploratory Study of Natural Killer Cells in Human SkinCompletedNCT00824889Not applicable
- Developing A Validated Measure of the Impact of Psoriasis on Chronic Quality of LifeCompletedNCT00823914
- Safety and Efficacy Study of Bimosiamose Cream to Treat PsoriasisCompletedNCT00823693Phase 2
- Use of Botulinum Toxin to Treat PsoriasisCompletedNCT00816517Phase 1
- Fumaric Acid Ester-PUVA Therapy Versus Acitretin -PUVA Therapy in Pustular Palmoplantar PsoriasisStatus unknownNCT00811005Phase 3
- Safety and Pharmacokinetics (PK) of Alefacept in Adolescent Subjects With Moderate to Severe PsoriasisCompletedNCT00808223Phase 2
- Chronic Plaque Psoriasis (Ps) RegistryCompletedNCT00799877
- A Single-Center Exploratory Study to Assess the Activity of CRx-197-002 in Plaque PsoriasisCompletedNCT00796211Phase 2
- Assess the Long-term Effectiveness and Safety of Amevive (Alefacept) in Subjects With Moderate to Severe Chronic Plaque PsoriasisTerminatedNCT00795353
- Safety and Tolerability of Repeat Courses of IM AlefaceptCompletedNCT00794807Phase 4
- Topical Application of AS101 for the Treatment of PsoriasisWithdrawnNCT00788424Phase 2
- Efficacy and Safety of Topical ALT-2074 (SYI-2074) for Treatment of Chronic Plaque PsoriasisTerminatedNCT00782613Phase 2
- Elocon vs Fluticasone in Localized Psoriasis (P03197)CompletedNCT00763529Phase 4
- Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of CD 2027 Spray in Adults With Plaque-type PsoriasisCompletedNCT00763503Phase 2
- A Phase I Study to Assess Novel Cream in a Psoriasis Plaque TestCompletedNCT00763204Phase 1
- A Phase I Study to Assess Novel Ointment in a Psoriasis Plaque TestCompletedNCT00762658Phase 1
- Narrow-Band UVB-Therapy in PsoriasisCompletedNCT00748020Phase 4
- To Demonstrate the Superior Efficacy of NYC 0462 Ointment Over That of the Placebo in the Treatment of Plaque PsoriasisWithdrawnNCT00747032Phase 3
- A Proof of Concept Study With 0.5% Roflumilast Cream in Patients With Mild to Moderate Plaque PsoriasisWithdrawnNCT00746434Phase 2
- An Open-Label, Multi-Center Trial in the Treatment of Subjects With Moderate to Severe Plaque Type PsoriasisCompletedNCT00725348Phase 2
- Evaluation of the Efficacy of Acitretin Therapy for Nail PsoriasisCompletedNCT00723437Phase 4
- Effectiveness and Safety of Topical Halobetasol Propionate in the Treatment of Patients With PsoriasisCompletedNCT00715975Phase 2/3
- Study Comparing the Efficacy and Safety of ABT-874 to Etanercept and Placebo in Subjects With Moderate to Severe Chronic Plaque PsoriasisCompletedNCT00710580Phase 3
- Potential Research Study Participant RegistryCompletedNCT00710489
- Combining Acitretin and Efalizumab in the Therapy of Chronic Plaque PsoriasisStatus unknownNCT00707070Phase 4
- LCD Solution Versus Calcipotriol Cream in the Treatment of Moderate Plaque PsoriasisCompletedNCT00705900Not applicable
- Effects of Capsaicin on the Structure, Distribution, and Function of Cutaneous Small Nerve Fibers in Psoriatic SkinTerminatedNCT00697034Phase 4
- Open-label Study to Evaluate Safety of Multiple Courses of IM Alefacept During Treatment of Chronic Plaque PsoriasisCompletedNCT00692172Phase 3
- Study Comparing the Efficacy and Safety of ABT-874 to Etanercept and Placebo in Subjects With Moderate to Severe Chronic Plaque PsoriasisCompletedNCT00691964Phase 3
- A Study of Safety and Efficacy Comparing ABT-874 Versus Methotrexate in Subjects With Moderate to Severe Plaque PsoriasisCompletedNCT00679731Phase 3
- A Study to Assess the Efficacy and Safety of Two Dosing Regimens of Alefacept in Subjects Weighing Between 100kg and 150kg With Moderate to Severe Chronic Plaque PsoriasisCompletedNCT00674063Phase 3
- A Study to Assess the Efficacy and Safety of Alefacept in Psoriasis Patients for Whom Conventional Treatment is Ineffective or InappropriateCompletedNCT00673556Phase 3
- Chondroitin Sulphate Efficay/Safety in Patients With Knee Osteoarthritis and PsoriasisCompletedNCT00669123Phase 4
- Dose Response and Safety Study of Topical Methotrexate for the Treatment of Fingernail PsoriasisStatus unknownNCT00666354Phase 2
- Analysis of Birth Outcomes of Swedish, Danish and Finnish Women Exposed to Remicade With Inflammatory Bowel Disease, Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, and PsoriasisCompletedNCT00658827
- Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Chronic Plaque PsoriasisCompletedNCT00646191Phase 2
- Study of Two Dosing Schedules of Adalimumab in Subjects With Moderate to Severe Chronic Plaque PsoriasisCompletedNCT00645905Phase 2
- Extension Study of Two Dosing Schedules of Adalimumab in Subjects With Moderate to Severe Chronic Plaque PsoriasisCompletedNCT00645892Phase 2
- Multicenter Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Chronic Plaque PsoriasisCompletedNCT00645814Phase 2
- A Study to Test the Design, Functionality, and Ergonomic Features of the AutoinjectorCompletedNCT00643526Early Phase 1
- UVB-311nm After Initial Slow Response to Adalimumab in PsoriasisStatus unknownNCT00638469Not applicable
- Primary UVB-311nm and Adalimumab in Psoriasis PatientsCompletedNCT00638261Not applicable
- Open Label Continuation Study in Moderate to Severe PsoriasisCompletedNCT00626002Phase 3
- Study of Dose-Effect of COL-121 Ointment in Patients With Plaque-Type PsoriasisCompletedNCT00625326Phase 2
- Double-Blind, Randomized, Placebo-controlled Comparison of CC-10004 in Subjects With Moderate to Severe Plaque Type PsoriasisCompletedNCT00606450Phase 2
- Open-Label,Single-Arm Pilot Study to Evaluate the Pharmacodynamics, Pharmacokinetics, Safety, and Preliminary Efficacy of CC1004 in Subjects With Severe Plaque Type PsoriasisCompletedNCT00604682Phase 2
- Genomic Study for the Prediction of Efficacy and Adverse Effects of CD11a Monoclonal Antibodies(Raptiva)CompletedNCT00602823
- A Safety and Efficacy Study of a Topical Gel for the Treatment of Mild to Moderate PsoriasisCompletedNCT00593177Phase 2
- Study Evaluating Safety of Etanercept in Treatment of Patients With Moderate to Severe Psoriasiswith EtanerceptCompletedNCT00581165Phase 4
- Efficacy and Tolerability Study of Topical Ciclosporin in a Psoriasis Plaque TestCompletedNCT00578370Phase 1/2
- A Study Comparing the Safety and Efficacy of Two Dosing Regimens of ABT-874 to Placebo in Subjects With Moderate to Severe Chronic Plaque PsoriasisCompletedNCT00570986Phase 3
- Study of CRx-191 to Assess Activity in Plaque PsoriasisCompletedNCT00557739Phase 2
- Topical PH-10 Aqueous Hydrogel and Photodynamic Therapy for PsoriasisTerminatedNCT00555646Phase 2
- Regulatory T Cells (Tregs) in Polymorphic Light EruptionCompletedNCT00555178
- Etanercept Plus UVB-311nm Phototherapy in PsoriasisCompletedNCT00550030Not applicable
- A Phase II Study of MEDI-507, Administered by Injection to Adults With PsoriasisCompletedNCT00540618Phase 2